Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia

British Journal of Haematology

Volumn 136, Issue 2, 2007, Pages 333-342

  Chagas Costa, Flávia ^a   Ferreira Da Cunha, Anderson ^a   Fattori, André ^a   De Sousa Peres, Tarcísio ^a   Gilson Lacerda Costa, Gustavo ^a   Ferraz Machado, Tiago ^a   Martins De Albuquerque, Dulcinéia ^a   Gambero, Sheley ^a   Lanaro, Carolina ^a   Olala Saad, Sara T ^a   Ferreira Costa, Fernando ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Cidade Universitaria   (Brazil)

Author keywords

Fetal haemoglobin; Gene expression; Hydroxycarbamide; Serial analysis of gene expression; Sickle cell anaemia

Indexed keywords

CENTAURIN BETA 1; EARLY GROWTH RESPONSE FACTOR 1; HYDROXYUREA; PROTEIN DERIVATIVE; RAS AND RAB INTERACTOR 3 PROTEIN; RHO GTPASE ACTIVATING PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; DRUG MECHANISM; ERYTHROID PRECURSOR CELL; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC TRANSCRIPTION; GLOBIN GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERIAL ANALYSIS OF GENE EXPRESSION; SICKLE CELL ANEMIA; SYMPTOM; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 33845872310     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06424.x     Document Type: Article

References (37)

1. Adragna, N.C., Fonseca, P. & Lauf, P.K. (1994) Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood, 83, 553-560.
2. Audic, S. & Claverie, J.M. (1997) The significance of digital gene expression profiles. Genome Research, 7, 986-995.
3. Bonafoux, B., Lejeune, M., Piquemal, D., Quere, R., Baudet, A., Assaf, L., Marti, J., Aguilar-Martinez, P. & Commes, T. (2004) Analysis of remnant reticulocyte mRNA reveals new genes and antisense transcripts expressed in the human erythroid lineage. Haematologica, 89, 1434-1438.
4. Bunn, H.F. (1997) Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine, 337, 762-769.
5. Chabardes-Garonne, D., Mejean, A., Aude, J.C., Cheval, L., Di Stefano, A., Gaillard, M.C., Imbert-Teboul, M., Wittner, M., Balian, C., Anthouard, V., Robert, C., Segurens, B., Wincker, P., Weissenbach, J., Doucet, A. & Elalouf, J.M. (2003) A panoramic view of gene expression in the human kidney. Proceedings of the National Academy of Sciences of the United States of America 100, 13710-13715.
6. de Chaldee, M., Gaillard, M.C., Bizat, N., Buhler, J.M., Manzoni, O., Bockaert, J., Hantraye, P., Brouillet, E. & Elalouf, J.M. (2003) Quantitative assessment of transcriptome differences between brain territories. Genome Research, 13, 1646-1653.
7. Charache, S. (1997) Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Seminars in Hematology, 34(3 Suppl. 3), 15-21.
8. Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. & Schechter, A.N. (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. The Journal of Clinical Investigation, 111, 231-239.
9. Demura, M., Takeda, Y., Yoneda, T., Furukawa, K., Usukura, M., Itoh, Y. & Mabuchi, H. (2002) Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Human Mutation, 19, 23-29.
10. Ewing, B. & Green, P. (1998) Base-calling of automated sequencer traces using Phred. II. Error probabilities. Genome Research, 8, 186-194.
11. Ferry, A.E., Baliga, S.B., Monteiro, C. & Pace, B.S. (1997) Globin gene silencing in primary erythroid cultures. An inhibitory role for interleukin-6. The Journal of Biological Chemistry, 272, 20030-20037.
12. Foley, H.A., Ofori-Acquah, S.F., Yoshimura, A., Critz, S., Baliga, B.S. & Pace, B.S. (2002) Stat3 beta inhibits gamma-globin gene expression in erythroid cells. The Journal of Biological Chemistry, 277, 16211-16219.
13. Fu, X. & Kamps, M.P. (1997) E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Molecular and Cellular Biology, 17, 1503-1512.
14. Gashler, A. & Sukhatme, V.P. (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Progress in Nucleic Acid Research and Molecular Biology, 50, 191-224.
15. Goossens, M. & Kan, Y.Y. (1981) DNA analysis in the diagnosis of hemoglobin disorders. Methods in Enzymology, 76, 805-817.
16. Halsey, C. & Roberts, I.A. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology, 120, 177-186.
17. Hashimoto, S., Nagai, S., Sese, J., Suzuki, T., Obata, A., Sato, T., Toyoda, N., Dong, H.Y., Kurachi, M., Nagahata, T., Shizuno, K., Morishita, S. & Matsushima, K. (2003) Gene expression profile in human leukocytes. Blood, 101, 3509-3513.
18. Ikuta, T., Ausenda, S. & Cappellini, M.D. (2001) Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proceedings of the National Academy of Sciences of the United States of America, 98, 1847-1852.
19. Jison, M.L., Munson, P.J., Barb, J.J., Suffredini, A.F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J.H., Shelhamer, J.H., Danner, R.L. & Gladwin, M.T. (2004) Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood, 104, 270-280.
20. Katoh, M. (2003) FNBP2 gene on human chromosome 1q32.1 encodes ARHGAP family protein with FCH, FBH, RhoGAP and SH3 domains. International Journal of Molecular Medicine, 11, 791-797.
21. Katoh, Y. & Katoh, M. (2004) Identification and characterization of ARHGAP27 gene in silico. International Journal of Molecular Medicine, 14, 943-947.
22. Krishnaraju, K., Hoffman, B. & Liebermann, D.A. (2001) Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. Blood, 97, 1298-1305.
23. Lal, A., Lash, A.E., Altschul, S.F., Velculescu, V., Zhang, L., McLendon, R.E., Marra, M.A., Prange, C., Morin, P.J., Polyak, K., Papadopoulos, N., Vogelstein, B., Kinzler, K.W., Strausberg, R.L. & Riggins, G.J. (1999) A public database for gene expression in human cancers. Cancer Research, 59, 5403-5407.
24. Lubarski, I., Pihakaski-Maunsbach, K., Karlish, S.J., Maunsbach, A.B. & Garty, H. (2005) Interaction with the Na, K-ATPase and tissue distribution of FXYD5 (related to ion channel). The Journal of Biological Chemistry, 280, 37717-37724.
25. Malago, Jr, W., Sommer, C.A., Del Cistia Andrade, C., Soares-Costa, A., Abrao Possik, P., Cassago, A., Santejo Silveira, H.C. & Henrique-Silva, F. (2005) Gene expression profile of human Down syndrome leukocytes. Croatian Medical Journal, 46, 647-656.
26. Margulies, E.H. & Innis, J.W. (2000) eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics, 16, 650-651.
27. May, P., Schniertshauer, U., Gerhartz, C., Horn, F. & Heinrich, P.C. (2003) Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation. Acta Biochimica Polonica, 50, 595-601.
28. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 29, e45.
29. Pollock, J.D. (2002) Gene expression profiling: methodological challenges, results, and prospects for addiction research. Chemistry and Physics of Lipids, 121, 241-256.
30. Schaefer, A., Kosa, F., Bittorf, T., Magocsi, M., Rosche, A., Ramirez-Chavez, Y., Marotzki, S. & Marquardt, H. (2004) Opposite effects of inhibitors of mitogen-activated protein kinase pathways on the egr-1 and beta-globin expression in erythropoietin-responsive murine erythroleukemia cells. Cellular Signalling, 16, 223-234.
31. Schwering, I., Brauninger, A., Distler, V., Jesdinsky, J., Diehl, V., Hansmann, M.L., Rajewsky, K. & Kuppers, R. (2003) Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes. Molecular Medicine, 9, 85-95.
32. Steinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. & Terrin, M. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA: the Journal of the American Medical Association, 289, 1645-1651.
33. Taylor, S.C., Shacks, S.J., Mitchell, R.A. & Banks, A. (1995) Serum interleukin-6 levels in the steady state of sickle cell disease. Journal of Interferon & Cytokine Research, 15, 1061-1064.
34. Tribioli, C., Droetto, S., Bione, S., Cesareni, G., Torrisi, M.R., Lotti, L.V., Lanfrancone, L., Toniolo, D. & Pelicci, P. (1996) An X chromosome-linked gene encoding a protein with characteristics of a rhoGAP predominantly expressed in hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America, 93, 695-699.
35. Varela, C., Cardenas, J., Melo, F. & Agosin, E. (2005) Quantitative analysis of wine yeast gene expression profiles under winemaking conditions. Yeast, 22, 369-383.
36. Velculescu, V.E., Zhang, L., Vogelstein, B. & Kinzler, K.W. (1995) Serial analysis of gene expression. Science, 270, 484-487.
37. Wang, M., Tang, D.C., Liu, W., Chin, K., Zhu, J.G., Fibach, E. & Rodgers, G.P. (2002) Hydroxyurea exerts bi-modal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways. British Journal of Haematology, 119, 1098-1105.